Social anxiety disorder: Designing a pharmacologic treatment strategy

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 9, 1999, Pages 20-26

  Pollack, Mark H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; ATENOLOL; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLONIDINE; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; GABAPENTIN; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; ONDANSETRON; PAROXETINE; PHENELZINE; PRAMIPEXOLE; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; UNCLASSIFIED DRUG; VENLAFAXINE;

ANAMNESIS; ANXIETY NEUROSIS; COMORBIDITY; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ALGORITHMS; BENZODIAZEPINES; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; HUMANS; MONOAMINE OXIDASE INHIBITORS; PHOBIC DISORDERS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032955011     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51 8-19
2. Schneier FR, Johnson J, Hornig CD, et al. Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry 1992;49: 282-288
3. Fyer AJ, Mannuzza S, Chapman TF, et al. A direct interview family study of social phobia. Arch Gen Psychiatry 1993;50:286-293
4. Otto MW, Pollack MH. Treatment strategies for panic disorder: a debate. Harv Rev Psychiatry 1994;2:166-170
5. Rosenbaum JF, Biederman J, Pollack RA, et al. The etiology of social phobia. J Clin Psychiatry 1994;55(6, suppl):10-16
6. Tancer ME. Neurobiology of social phobia. J Clin Psychiatry 1993;54 (12, suppl):26-30
7. James IM, Griffith DNW, Pearson RM, et al. Effect of oxprenolol on stage-fright in musicians. Lancet 1977;2:952-954
8. Gorman JM, Liebowitz MR, Fyer AJ, et al. Treatment of social phobia with atenolol. J Clin Psychopharmacol 1985;5:298-301
9. Liebowitz MR, Schneier F, Campeas R, et al. Phenelzine vs atenolol in social phobia: a placebo controlled comparison. Arch Gen Psychiatry 1992; 49:290-300
10. Liebowitz MR, Fyer AJ, Gorman JM, et al. Phenelzine in social phobia. J Clin Psychopharmacol 1986;6:93-98
11. Versiani M, Mundim FD, Nardi AE, et al. Tranylcypromine in social phobia. J Clin Psychopharmacol 1988;8:279-283
12. Gelernter CS, Uhde TW, Cimbolic P, et al. Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry 1991;48:938-945
13. Versiani M, Nardi AE, Mundim FD, et al. Pharmacotherapy of social phobia: a controlled study with moclobemide and phenelzine. Br J Psychiatry 1992;161:353-360
14. Noyes R, Moroz F, Davidson J, et al. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 1997;17:247-254
15. Pollack M, Gould R The pharmacotherapy of social phobia. Int Clin Psychopharmacol 1996;11:71-75
16. Versiani M, Nardi AE, Mundim FD, et al. The long-term treatment of social phobia with moclobemide. Int Clin Psychopharmacol 1996;11(suppl 3): 83-88
17. Davidson JRT, Ford SM, Smith RD, et al. Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 1991;52(11, suppl):16-20
18. Lydiard RB, Laraia MT, Howell EF, et al. Alprazolam in the treatment of social phobia. J Clin Psychiatry 1988;49:17-19
19. Reich J, Yates W. A pilot study of treatment of social phobia with alprazolam. Am J Psychiatry 1988;145:590-594
20. Reiter SR, Pollack MH, Rosenbaum JF, et al. Clonazepam for the treatment of social phobia. J Clin Psychiatry 1990;51:470-472
21. Davidson JRT, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428
22. Magee WJ, Eaton WW, Wittchen HU, et al. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry 1996;53:159-168
23. Weiller JE, Bisserbe PC, Lepine P, et al. Social phobia in general health care: an unrecognized undertreated disabling disorder. Br J Psychiatry 1996;168:169-174
24. Black B, Uhde TW, Tancer ME. Fluoxetine for the treatment of social phobia. J Clin Psychopharmacol 1992;12:293-295
25. Lepola U, Koponen H, Leinonen E. Citalopram in the treatment of social phobia: a report of three cases. Psychopharmacology (Berl) 1994;27: 186-188
26. Ringold AL. Paroxetine efficacy in social phobia [letter]. J Clin Psychiatry 1994;55:363-364
27. Schneier FR, Chin SJ, Hollander E, et al. Fluoxetine in social phobia [letter]. J Clin Psychopharmacol 1992;12:62-63
28. Sternbach H. Fluoxetine treatment of social phobia [letter]. J Clin Psychopharmacol 1990;10:230
29. Van Ameringen M, Mancini C, Streiner D. Sertraline in social phobia. J Affect Disord 1994;31:141-145
30. Van Ameringen M, Mancini C, Streiner DL. Fluoxetine efficacy iti social phobia. J Clin Psychiatry 1993;54:27-32
31. Kelsey JE. Venlafaxine in social phobia. Psychopharmacol Bull 1995;31: 767-771
32. Worthington JJ III, Zucker BG, Fones CS, et al. Nefazodone for social phobia: a clinical case study. Depress Anxiety 1998;8:131-133
33. van Vliet IM, den Boer JA, Westenberg HGM. Psychopharmacological treatment of social phobia: a double-blind, placebo-controlled study with fluvoxamine. Psychopharmacology (Berl) 1994;115:128-134
34. Stein MB, Fyer AJ, Davidson JRT, et al. Fluvoxamine treatment of social phobia: a double-blind placebo-controlled study. Am J Psychiatry. In press
35. Katzelnick DJ, Kobak KA, Greist JH, et al. Sertraline in social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry 1995; 152:1368-1371
36. Pitts CD, Oakes R, Gergel IP. Effectiveness of paroxetine in the treatment of generalized social phobia. Presented at the 35th annual meeting of the American College of Neuropsychopharmacology; December 9-13, 1996; San Juan, Puerto Rico
37. Stein MB, Liebowitz MR, Lydiard RB, et al. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized, controlled trial. JAMA 1998;280:708-713
38. Carpenter DJ, Pitts CD, Oakes R, et al. A randomized, double-blind, fixed-dose comparison of paroxetine (20 mg, 40 mg, 60 mg) and placebo in the treatment of social anxiety disorder. Presented at the 38th annual meeting of the New Clinical Drug Evaluation Unit; June 11, 1998; Boca Raton, Fla
39. Stein MB, Chartier MJ, Ilazen AL, et al. Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind, placebo-controlled discontinuation. J Clin Psychopharmacol 1996;16:218-222
40. Smoller JS, Pollack MH. Social phobia and generalized anxiety disorder: psychopharmacological treatment. In: Pollack MH, Otto MW, Rosenbaum JF, eds. Challenges in Clinical Practice: Pharmacologic and Psychosocial Strategies. New York, NY: Guilford Press; 1996:141-170
41. Pande AC, Davidson JRT, Greist JH, et al. A placebo-controlled study of gabapentin in social phobia. Presented at the 36th annual meeting of the American College of Neuropsychopharmacology; December 8, 1997; Waikoloa, Hawaii
42. Munjack DJ, Burns J, Baltazar PL, et al. A pilot study of buspirone in the treatment of social phobia. J Anxiety Disord 1991;5:87-98
43. Schneier FR, Saoud JB, Campeas R, et al. Buspirone in social phobia. J Clin Psychopharmacol 1993;13:251-256
44. Clark DB, Agras WS. The assessment and treatment of performance anxiety in musicians. Am J Psychiatry 1991;148:598-605
45. Van Ameringen M, Mancini C, Wilson C. Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia. J Affect Disord 1996;39:115-121
46. Benca R, Matuzas W, Al-Sadir J. Social phobia, MVP, and response to imipramine [letter]. J Clin Psychopharmacol 1986;6:50-51
47. Pecknold JC, McClure DJ, Appeltauer L, et al. Does tryptophan potentiate clomipramine in the treatment of agoraphobic and social phobic patients? Br J Psychiatry 1982;140:484-490
48. Emmanuel NP, Johnson M, Villareal G. Imipramine in the treatment of social phobia: a double-blind study. Presented at the 36th annual meeting of the American College of Neuropsychopharmacology; December 8, 1997; Waikoloa, Hawaii
49. Emmanuel NP, Lydiard RB, Ballenger JC. Treatment of social phobia with bupropion [letter]. J Clin Psychopharmacol 1991;11:276-277
50. Goldstein S. Treatment of social phobia with clonidine. Biol Psychiatry 1987;22:369-372
51. 3 antagonist, ondansetron, in social phobia. Presented at the 33rd annual meeting of the American College of Neuropsychopharmacology; December 13, 1994; San Juan, Puerto Rico
52. Gould RA, Otto MW. Cognitive-behavioral treatment of social phobia and generalized anxiety disorder. In: Pollack MH, Otto MW, Rosenbaum JF, eds. Challenges in Clinical Practice: Pharmacologic and Psychosocial Strategies. New York, NY: Guilford Press; 1996:171-200